| Literature DB >> 21383918 |
Sukrat Sinha1, Shanthy Sundaram, Anand Prakash Singh, Ashutosh Tripathi.
Abstract
Visceral leishmaniasis is a macrophage associated disorder which leads to a profound decrease in the natural immunotherapeutic potential of the infected subjects to combat the disease. The major surface glycoprotein gp63 has been found to be a significant vaccine candidate against visceral leishmaniasis. The current study addresses the levels of similarity and identity in the gp63 obtained from different species of Leishmania viz donovoni, chagasi and infantum linked to the cause of visceral leishmaniasis. The results from BLAST, Phylogram and Cladogram studies indicate significant identity, similarity and conservation of important residues in the protein which lead us to conclude that a common gp63 based vaccine can be used as a therapeutical tool against visceral leishmaniasis caused by different species strains of leishmania.Entities:
Keywords: Basic Local Alignment Search Tool (BLAST); Cladogram; Glycoprotein 63(gp63); Phylogram; Visceral leishmaniasis (VL)
Year: 2011 PMID: 21383918 PMCID: PMC3046035 DOI: 10.6026/97320630005320
Source DB: PubMed Journal: Bioinformation ISSN: 0973-2063
Figure 2T-COFFEE showing the conservation of aminoacid residues of gp63 in different species strains of Leishmania associated with Visceral Leishmaniasis
Figure 1Cladogram and Phylogram analysis of gp63 sequences of different species strains of Leishmania associated with Visceral Leishmaniasis